{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T15:28:55Z","timestamp":1751038135394},"reference-count":92,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2013,1,30]],"date-time":"2013-01-30T00:00:00Z","timestamp":1359504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2013,10]]},"abstract":"<jats:p>The introduction of plerixafor as a peripheral blood stem cell mobilization agent has allowed more patients with multiple myeloma, non\u2010Hodgkin's lymphoma, and Hodgkin's disease to mobilize sufficient hematopoietic progenitor cells (<jats:styled-content style=\"fixed-case\">HPC<\/jats:styled-content>s) to proceed to autologous transplantation. Because of the high cost of plerixafor, it is not routinely used in all patients undergoing <jats:styled-content style=\"fixed-case\">HPC<\/jats:styled-content> mobilization. If cost were not an issue, an argument could be made that plerixafor could be added to every mobilization regimen, but cost is an issue so in an attempt to be more cost\u2010effective, many centers have limited plerixafor use to patients who have failed or who are predicted to fail collection of adequate numbers of cells by other methods. Additionally, plerixafor is now under investigation both for <jats:styled-content style=\"fixed-case\">HPC<\/jats:styled-content> collection of healthy donors for allogeneic stem cell transplantation and as an adjunct therapy (i.e., chemosensitizing agent) for acute leukemias. This article briefly reviews the role of plerixafor in autologous and allogeneic transplantation as well as its emerging role in the treatment of acute leukemias. Emphasis is placed on the choice of appropriate patients for plerixafor use to assure an adequate stem cell yield while maximizing the cost effectiveness of using plerixafor. The role of prophylactic collections and future areas of research are also presented.<\/jats:p>","DOI":"10.1111\/trf.12102","type":"journal-article","created":{"date-parts":[[2013,1,30]],"date-time":"2013-01-30T11:53:40Z","timestamp":1359546820000},"page":"2314-2326","source":"Crossref","is-referenced-by-count":17,"title":["The evolving role of plerixafor in hematopoietic progenitor cell mobilization"],"prefix":"10.1111","volume":"53","author":[{"given":"Yvette C.","family":"Tanhehco","sequence":"first","affiliation":[{"name":"Department of Pathology and Cell Biology Columbia University  New York New York"},{"name":"Abramson Cancer Center University of Pennsylvania  Philadelphia Pennsylvania"},{"name":"Department of Pathology and Laboratory Medicine University of Pennsylvania  Philadelphia Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan T.","family":"Vogl","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology Columbia University  New York New York"},{"name":"Abramson Cancer Center University of Pennsylvania  Philadelphia Pennsylvania"},{"name":"Department of Pathology and Laboratory Medicine University of Pennsylvania  Philadelphia Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward A.","family":"Stadtmauer","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology Columbia University  New York New York"},{"name":"Abramson Cancer Center University of Pennsylvania  Philadelphia Pennsylvania"},{"name":"Department of Pathology and Laboratory Medicine University of Pennsylvania  Philadelphia Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Una","family":"O'Doherty","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology Columbia University  New York New York"},{"name":"Abramson Cancer Center University of Pennsylvania  Philadelphia Pennsylvania"},{"name":"Department of Pathology and Laboratory Medicine University of Pennsylvania  Philadelphia Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,1,30]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V19.6.702.702"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V47.6.1031.1031"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V71.3.723.723"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.10.2547"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/stem.5530010401"},{"key":"e_1_2_9_7_1","first-page":"301","article-title":"Transplantation with blood stem cells","volume":"17","author":"Zander AR","year":"1991","journal-title":"Blood Cells"},{"key":"e_1_2_9_8_1","first-page":"19","article-title":"Peripheral blood and bone marrow hematopoietic stem cells: are they the same?","volume":"20","author":"Janssen WE","year":"1993","journal-title":"Semin Oncol"},{"key":"e_1_2_9_9_1","first-page":"15","article-title":"Peripheral blood progenitor cells: a replacement for marrow transplantation?","volume":"23","author":"Champlin RE","year":"1996","journal-title":"Semin Oncol"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)92012-0"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V72.6.2074.2074"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)90711-3"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.7.2233"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.7.1709.1709"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1M289"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.1.43"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.9.1824"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1999.39199116893.x"},{"key":"e_1_2_9_19_1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood.V85.1.275.bloodjournal851275","article-title":"Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte\u2010macrophage colony\u2010stimulating factor (GM\u2010CSF) or G\u2010CSF: potential role in allogeneic marrow transplantation","volume":"85","author":"Lane TA","year":"1995","journal-title":"Blood"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni813"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.21043"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.30.5.485"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2011.601737"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.63"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702879"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/14653240701452800"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.01.008"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2012.09.003"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.01.005"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.119"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.127"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.7209"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-08-174946"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.409"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2005.04222.x"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.08.011"},{"key":"e_1_2_9_37_1","doi-asserted-by":"crossref","unstructured":"RettigMP LopezS McFarlandK DiPersioJ.Rapid and prolonged mobilization of human CD34+ hematopoietic stem cells following intravenous (IV) administration of plerixafor. 53rd ASH Annual Meeting and Exposition. Orlando FL 2010: Poster 2261.","DOI":"10.1182\/blood.V116.21.2261.2261"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2011.12.009"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2011.01605.x"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-02-0468"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.3816\/SCT.2004.n.008"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.118"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.2147\/CE.S7801"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.11.028"},{"key":"e_1_2_9_45_1","doi-asserted-by":"crossref","unstructured":"NazhaA CookR VoglDT ManganPA HummelK CunninghamK LugerS PorterD SchusterSJ O'DohertyU SellM SiegelDL StadtmauerEA.Plerixafor and G\u2010CSF versus cyclophosphamide and G\u2010CSF for stem cell mobilization in patients with multiple myeloma 51st. American Society of Hematology Annual Meeting and Exposition. New Orleans LA 2009: Poster 2146.","DOI":"10.1182\/blood.V114.22.2146.2146"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.249"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2010.01520.x"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.07.004"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701843213"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704466"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2008.09.012"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705298"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.11.012"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-010-1098-7"},{"key":"e_1_2_9_55_1","first-page":"200","article-title":"Plerixafor in poor stem cell mobilizers: the Belgian compassionate use program","volume":"66","author":"Selleslag D","year":"2011","journal-title":"Acta Clin Belg"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2010.12.036"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.128"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.93"},{"key":"e_1_2_9_59_1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.17925\/EOH.2010.04.0.24","article-title":"The use of plerixafor for blood stem cell mobilization reduces the frequency of mobilization failure in patients planned to undergo autologous stem cell transplantation","volume":"4","author":"Josefsen D","year":"2010","journal-title":"Eur Haematol"},{"issue":"2","key":"e_1_2_9_60_1","first-page":"S258","article-title":"Successful peripheral blood stem cell harvest in mobilization\u2010refractory lymphoma patients","volume":"45","author":"Segel E","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2011.03349.x"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702531"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770000215"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.4.1554"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2011.133"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2011.03206.x"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2011.03136.x"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.08.018"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.20239"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-205013"},{"key":"e_1_2_9_71_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404801"},{"key":"e_1_2_9_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2405100"},{"key":"e_1_2_9_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.02.011"},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-297325"},{"key":"e_1_2_9_75_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112704"},{"key":"e_1_2_9_76_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-359331"},{"key":"e_1_2_9_77_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-214403"},{"key":"e_1_2_9_78_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403341"},{"key":"e_1_2_9_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.04.013"},{"key":"e_1_2_9_80_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03478.x"},{"key":"e_1_2_9_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704355"},{"key":"e_1_2_9_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02202.x"},{"key":"e_1_2_9_83_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181ac14ce"},{"key":"e_1_2_9_84_1","doi-asserted-by":"publisher","DOI":"10.1586\/ehm.09.54"},{"key":"e_1_2_9_85_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.98"},{"key":"e_1_2_9_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08547.x"},{"key":"e_1_2_9_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2010.07.001"},{"key":"e_1_2_9_88_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-162123"},{"key":"e_1_2_9_89_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-05-158311"},{"key":"e_1_2_9_90_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404684"},{"key":"e_1_2_9_91_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402998"},{"key":"e_1_2_9_92_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.76"},{"key":"e_1_2_9_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.08.005"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftrf.12102","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.12102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T19:52:47Z","timestamp":1696017167000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.12102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,30]]},"references-count":92,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["10.1111\/trf.12102"],"URL":"https:\/\/doi.org\/10.1111\/trf.12102","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,30]]}}}